3.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.98
Aprire:
$3.94
Volume 24 ore:
899.20K
Relative Volume:
0.74
Capitalizzazione di mercato:
$186.14M
Reddito:
$234.96M
Utile/perdita netta:
$-4.30M
Rapporto P/E:
-19.52
EPS:
-0.1988
Flusso di cassa netto:
$-1.24M
1 W Prestazione:
-12.61%
1M Prestazione:
+45.32%
6M Prestazione:
-39.38%
1 anno Prestazione:
-36.39%
Lifemd Inc Stock (LFMD) Company Profile
Nome
Lifemd Inc
Settore
Industria
Telefono
(866) 351-5907
Indirizzo
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
3.88 | 186.14M | 234.96M | -4.30M | -1.24M | -0.1988 |
|
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-16 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-06-18 | Reiterato | BTIG Research | Buy |
| 2024-12-10 | Iniziato | Lake Street | Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-23 | Ripresa | B. Riley Securities | Buy |
| 2024-06-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Iniziato | Craig Hallum | Buy |
| 2023-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2022-03-10 | Iniziato | Colliers Securities | Buy |
| 2021-10-04 | Ripresa | B. Riley Securities | Buy |
Mostra tutto
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Bitget
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - TradingView
[144] LifeMD, Inc. SEC Filing - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
If You Invested $1,000 in Lifemd, Inc. (LFMDP) - Stock Titan
If You Invested $1,000 in Lifemd Inc (LFMD) - Stock Titan
LifeMD appoints new CFO; shares up - MSN
How The LifeMD (LFMD) Story Is Shifting On GLP‑1 Growth And Higher 2026 Targets - Yahoo Finance
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - GuruFocus
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com India
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - markets.businessinsider.com
LifeMD Inc announced appointment of Atul Kavthekar as chief financial officer - marketscreener.com
LifeMD names Atul Kavthekar as CFO, announces leadership changes - Investing.com
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho - MarketBeat
LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer - TradingView
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
Mizuho upgrades LifeMD stock rating on weight-loss outlook By Investing.com - Investing.com Australia
Mizuho upgrades LifeMD stock rating on weight-loss outlook - Investing.com Nigeria
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Nigeria
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance - Yahoo Finance
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
LifeMD, Inc. (LFMD) reports Q4 loss, tops revenue estimates - MSN
LifeMD (LFMD) Analyst Rating: Freedom Capital Markets Raises Pri - GuruFocus
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD surges 11.5% on Q4 earnings beat, FY guidance By Investing.com - Investing.com Nigeria
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
Lifemd Inc Azioni (LFMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):